Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Payables (2016 - 2025)

Proto Labs' Payables history spans 15 years, with the latest figure at $15.1 million for Q4 2025.

  • For Q4 2025, Payables fell 2.58% year-over-year to $15.1 million; the TTM value through Dec 2025 reached $15.1 million, down 2.58%, while the annual FY2025 figure was $15.1 million, 2.58% down from the prior year.
  • Payables for Q4 2025 was $15.1 million at Proto Labs, down from $17.4 million in the prior quarter.
  • Across five years, Payables topped out at $26.0 million in Q2 2021 and bottomed at $15.0 million in Q3 2024.
  • The 5-year median for Payables is $16.7 million (2022), against an average of $18.0 million.
  • The largest annual shift saw Payables surged 48.31% in 2021 before it plummeted 39.93% in 2022.
  • A 5-year view of Payables shows it stood at $25.4 million in 2021, then crashed by 31.57% to $17.4 million in 2022, then decreased by 9.91% to $15.6 million in 2023, then dropped by 0.84% to $15.5 million in 2024, then dropped by 2.58% to $15.1 million in 2025.
  • Per Business Quant, the three most recent readings for PRLB's Payables are $15.1 million (Q4 2025), $17.4 million (Q3 2025), and $15.6 million (Q2 2025).